mtmt
The Hungarian Scientific Bibliography
XML
JSON
Public search
Magyarul
Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024)
English Scientific
Published: , 217 p.
2024
Conference:
Conference on Pharmacology, Pharmacokinetics & Innovation, HUPHAR 2024 2024-06-05 [Mátraháza, Hungary]
Identifiers
MTMT: 35000600
Full text:
https://huphar.org/huphar2024/wp-content/uploads/2024/06/HUPHAR2024-Programfuzet-4.pdf
Chapters
Bodó Angelika et al. A pilot study using DREADD technology to develop a novel model of cognitive impairment. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024)
Szőcs Levente et al. Methylated cyclodextrins: understanding quality – bioactivity relationships. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) p. F-KA1-4
Kocsis Márton et al. Thymic modulation of immune checkpoint inhibitor-induced cardiotoxicity: new perspectives in immunotherapy. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) p. 58
Al-Khrasani Mahmoud et al. T-KB1-7 GLYCINE TRANSPORTER 1 AND AT1 RECEPTOR INHIBITORS: NOVEL STRATEGIES TO DECREASE MORPHINE ANALGESIC TOLERANCE. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 73-73
Zádori Zoltán S. et al. T-KA3-3 SEARCHING FOR NEW TARGETS FOR TREATMENT OF NSAID ENTEROPATHY. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 82-82
Varga Zoltán V. et al. Antidiabetic drugs repurposed for heart failure. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 93-93
Onódi Zsófia et al. T-KC3-4 ANTI-GOUT MEDICATIONS REPURPOSED FOR HEART FAILURE. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 94-94
Hegedűs I. Zsombor et al. EXPRESSION OF KEY IMMUNE CHECKPOINTS IN END-STAGE HEART FAILURE. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 100-100
Dávid Czimer et al. FROM TANK TO BED IN PXE? USING ZEBRAFISH TO SEARCH FOR PSEUDOXANTHOMA ELASTICUM TREATMENTS. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 101-101
Barbara Nikolett Borsos et al. The clinical significance of epigenetic, RNAPII and transcriptional variabilities occurring in clear cell renal cell carcinoma as a potential prognostic marker. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 114-114
Pankotai Tibor. The clinical significance of epigenetic, RNAPII and transcriptional variabilities occurring in clear cell renal cell carcinoma as a potential prognostic marker. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) p. 114
Morotz Gabor M et al. Adrenal inflammation in heart failure. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 116-116
Viktor Szegedi et al. Aging-associated weakening of the action potential in fast-spiking interneurons in the human neocortex. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 117-117
Ambrus Rita et al. Application of Cyclodextrins in Traditional and Alternative Drug Formulations; Case Studies. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 124-124
Kerpel-Fronius Sandor et al. F-KC1-2 THE VALUE AND IMPORTANCE OF A PROFESSIONAL ETHICAL CODE FOR MEDICINES DEVELOPMENT. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 135-135
Bencsik Péter et al. F-KA3-2 CARDIOPROTECTION BY EXOGENOUS MICRORNA-125B* MIMIC IN A MOUSE MODEL OF ACUTE MYOCARDIAL INFARCTION. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 140-140
Görbe Anikó et al. HIDDEN CARDIOTOXICITY AND CARDIOPROTECTION: DEVELOPMENT OF PRECLINICAL TEST PLATFORMS FROM IN VITRO TO IN VIVO MODELS. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 142-142
Ágg Bence et al. F-KA4-4 NETWORK THEORETICAL AND MACHINE-LEARNING-BASED ANALYSIS OF THE INTERACTOME FOR THE DEVELOPMENT OF OLIGONUCLEOTIDE THERAPIES IN CARDIOVASCULAR DISEASES. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 154-154
Ferdinandy Péter. F-KA4-5 DEVELOPMENT OF SMALL NON-CODING RNA THERAPEUTICS: THE EXAMPLE OF PROTECTOMIR MIR-450A MIMIC. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 155-155
Balogh Olivér et al. TOWARD MACHINE-ASSISTED CAUSALITY ASSESSMENT IN PHARMACOVIGILANCE: USING CONTRASTIVE LEARNING TO CREATE VECTOR REPRESENTATIONS OF ADVERSE EVENTS FROM SPONTANEOUS REPORTS. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 163-164
Haghighi Samaneh et al. Unraveling the Impact of NSAIDs on Kidney Function: Autophagy, Fibrosis, and Dose-Dependent Morphological Insights. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 166-167
Nagy Regina N et al. CARDIOPROTECTIVE MICRORNAS (PROTECTOMIRS) IN A PIG MODEL OF ACUTE MYOCARDIAL INFARCTION AND CARDIOPROTECTION BY ISCHEMIC CONDITIONING: MIR-450A AND MIR-451. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 168-168
Galambos Anna Rita et al. GLYCINE TRANSPORTER 1 INHIBITORS DELAY MORPHINE ANALGESIC TOLERANCE IN RATS. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 169-170
Szabó Lilla et al. DECREASED LEVEL OF THE VIRAL RESTRICTION PROTEIN IFITM3 IN HEART FAILURE. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 169-169
Essmat Nariman et al. TOLPERISONE/PREGABALIN COMBINATION PRODUCES ACUTE ANTIALLODYNIC ACTION IN RAT MONONEUROPATHIC PAIN. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 170-171
Takács-Lovász Krisztina et al. ALTERED METABOLITE PROFILE IN A POTENTIAL MIGRAINE-MIMICKING ANIMAL MODEL. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 177-178
Wachtl Gerda et al. Fatty Acid Amide Hydrolase (FAAH) Inhibition Aggravates Indomethacin-Induced Enteropathy in Mice. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 178-179
Ernyey Alíz Judit et al. RATS USE RANDOM STRATEGY FOR SOLVING COMPLICATED COGNITIVE TASKS. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 179-180
Á. Benő Alexandra et al. Identifying Gene Expression Patterns in SCLC Development. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 181-181
Makkos András et al. N VITRO BREAST CANCER CELL LINE PANEL TO MODEL AND VALIDATE A PRECISION ONCOLOGY PROGRAM. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 183-184
Kolos Nemes et al. PREDICTIVE INSIGHTS INTO DRUG RESPONSE: INTEGRATING PROTEOMICS AND GENE EXPRESSION WITH MACHINE LEARNING IN SMALL CELL LUNG CANCER. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 185-185
Váradi Barnabás et al. TRANSCRIPTOMIC COMPARISON OF MOUSE MODELS OF HEART FAILURE INDUCED BY CHRONIC ANGIOTENSIN-II INFUSION OR TRANSVERSE AORTIC CONSTRICTION. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 187-187
Marton Szandra et al. MPACT OF INDICATION RESTRICTION AND DIRECT HEALTHCARE PROFESSIONAL COMMUNICATION LETTERS ON PRESCRIBING PATTERNS OF TOLPERISONE IN HUNGARY. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 192-193
Weber Bennet Y et al. CHRONIC ROFECOXIB TREATMENT OF RATS CAUSES MAJOR CHANGES IN PROTEIN EXPRESSION AND PHOSPHORYLATION IN THE HEART. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 196-197
Alsou’b Dima Fayiz et al. MITOCHONDRIAL UNCOUPLING PROTEIN-2 IS INVOLVED IN ACUTE NEUROGENIC MECHANICAL AND THERMAL HYPERALGESIA IN FEMALE RATS. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 201-201
Noémi Bencze et al. THE NOVEL MULTITARGET SEMICARBAZIDE-SENSITIVE AMINE OXIDASE INHIBITOR SZV-1287 DECREASES THE VIABILITY OF DIFFERENT CANCER CELL LINES. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 202-203
Haghighi Arezoo et al. Investigating the Relationship Between Antimicrobial Peptides and Gut Microbiota in Nsaid Enteropathy. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 205-206
Paál Ágnes et al. EFFECTS OF BLUNTING ANNEXIN A1 EXPRESION IN SMALL CELL LUNG CANCER CELL LINES. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 208-209
Somogyi Orsolya et al. A SELECTIVE CDK12 INHIBITION IN COMBINATION WITH PARP INHIBITION SENSITIZE PARP INHIBITOR RESISTANT BREAST CANCER CELL LINES. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 211-211
Szabados Tamara et al. Ardioprotective Effect of Ischemic Preconditioning in the Presence of Ulcerative Colitis. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 211-212
Hambalkó Szabolcs et al. MAO-B INHIBITION BY SELEGILINE BLUNTS CARDIAC FUNCTIONS IMPROVED BY HIGH-FAT DIET: ROLE OF INFLAMMATION, APOPTOSIS, AND CALCIUM-HANDLING. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 215-216
Kovácsházi Csenger et al. EFFECT OF HYPERCHOLESTEROLEMIA ON CIRCULATING AND CARDIOMYOCYTE-DERIVED EXTRACELLULAR VESICLES. (2024) In: Conference on Pharmacology, Pharmacokinetics & Innovation (HUPHAR 2024) pp. 216-216
Citation styles:
IEEE
ACM
APA
Chicago
Harvard
CSL
Copy
Print
2026-10-16 16:05
×
Export list as bibliography
Citation styles:
IEEE
ACM
APA
Chicago
Harvard
Print
Copy
